Bladder Cancer

Thromboembolic Events Common With Neoadjuvant Chemo for MIBC

Thromboembolic Events Common With Neoadjuvant Chemo for MIBC

Before and after radical cystectomy, thromboembolic events are common in bladder cancer patients who undergo neoadjuvant chemotherapy.

Low Vitamin D Linked to Bladder Cancer

Low Vitamin D Linked to Bladder Cancer

Low levels of vitamin D in the blood may prevent the cells within the bladder from stimulating an adequate response to abnormal cells.

Tumor Features Predict Post-Cystectomy Recurrence

Tumor Features Predict Post-Cystectomy Recurrence

Predictors of distant recurrences after robot-assisted radical cystectomy were mainly dictated by pathological tumor characteristics.

Nivolumab Shows Promise for Metastatic Urothelial Cancer

Nivolumab Shows Promise for Metastatic Urothelial Cancer

By

Based on a small study, investigators report encouraging efficacy and safety.

Bladder Cancer Progression Linked to Collagen Changes

Bladder Cancer Progression Linked to Collagen Changes

By

Increased type I collagen mRNA expression in the extracellular matrix microenvironment is associated with poor progression-free survival.

Infection Occurs in One Fourth of Radical Cystectomy Patients

Infection Occurs in One Fourth of Radical Cystectomy Patients

By

Patients who underwent a radical cystectomy (RC) developed postoperative infection after a median of 13 days.

Tight Glycemic Control May Help Diabetic NMIBC Patients

Tight Glycemic Control May Help Diabetic NMIBC Patients

By

Patients with diabetes had a significant 42% increased risk of recurrence of cancer and 79% increased risk of progression.

BCG Alone for Bladder CIS Offers Better Long-Term Outcomes

BCG Alone for Bladder CIS Offers Better Long-Term Outcomes

By

This approach is associated with a 26% decreased risk of disease recurrence at 15 years compared with alternating therapy with mitomycin C.

Tumor Site in Bladder Adenocarcinoma Predicts Survival Outcomes

Tumor Site in Bladder Adenocarcinoma Predicts Survival Outcomes

By

Tumors in the dome or urachus confer a better prognosis than those in the lateral wall and base, study finds.

Bladder Cancer Urine Test Accurate

Bladder Cancer Urine Test Accurate

By

Assay could cut down on cystoscopies, researchers say.

8% of Cancer Patients Develop a Second Malignancy

8% of Cancer Patients Develop a Second Malignancy

Second cancer was fatal in 55% of the cases studied.

Metformin May Have a Protective Effect in Bladder Cancer Patients

Metformin May Have a Protective Effect in Bladder Cancer Patients

By

Diabetics taking the drug had a significant 68% decreased risk of grade progression compared with diabetics not on the drug.

New Study Supports Use of Trimodal Therapy for MIBC

New Study Supports Use of Trimodal Therapy for MIBC

By

Researchers find no difference in 5-year disease-specific survival between multi-disciplinary bladder-sparing approach and radical cystectomy.

Early Recurrence After Laparoscopic Radical Cystectomy Explored

Early Recurrence After Laparoscopic Radical Cystectomy Explored

During first 24 months, 8.7% of patients with favorable pathological characteristics had progressed.

Gender Differences in Chemotherapy for Stage IV Bladder Cancer

Gender Differences in Chemotherapy for Stage IV Bladder Cancer

Women with stage IV bladder cancer have a lower median overall survival rate when compared to men.

Immunotherapy Helps Advanced Bladder Cancer Patients

Immunotherapy Helps Advanced Bladder Cancer Patients

About a quarter of older patients deemed too frail for chemo responded to atezolizumab.

Achieving 4 Lifestyle Standards May Reduce Cancer Mortality

Achieving 4 Lifestyle Standards May Reduce Cancer Mortality

Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol.

Drug Cleared for Refractory Advanced Bladder Cancer

Drug Cleared for Refractory Advanced Bladder Cancer

By

Atezolizumab received accelerated FDA approval for patients whose disease has progressed despite platinum-based chemotherapy.

Leisure Activity Linked With Lower Risk of Several Cancers

Leisure Activity Linked With Lower Risk of Several Cancers

Findings for self-reported leisure-time physical activity of moderate to vigorous intensity.

Prostate, Bladder Cancer Linked to BPH

Prostate, Bladder Cancer Linked to BPH

By

In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.

Pioglitazone Use, Bladder Cancer Linked

Pioglitazone Use, Bladder Cancer Linked

By

Bladder cancer risk increases with longer duration of use.

CKD Is a Risk Factor for UTUC

CKD Is a Risk Factor for UTUC

By

Researchers found elevated incidences of upper tract urothelial carcinoma (UTUC) in patients with CKD.

Cytoreductive RC Aids Survival of Metastatic Bladder Cancer Patients

Cytoreductive RC Aids Survival of Metastatic Bladder Cancer Patients

By

Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).

Neoadjuvant Chemo Rarely Used in Upper Tract Urothelial Cancer

Neoadjuvant Chemo Rarely Used in Upper Tract Urothelial Cancer

By

Therapy used in less than 5% of cases, even in those with higher clinical stage.

Bladder Preservation Therapy for MIBC Predicts Worse Survival

Bladder Preservation Therapy for MIBC Predicts Worse Survival

By

Mortality risk decreases with increasingly stringent BPT compared with radical cystectomy.

Key Micronutrients Lacking in Black Bladder Cancer Survivors' Diets

Key Micronutrients Lacking in Black Bladder Cancer Survivors' Diets

By

African American survivors had lower intakes of 8 select micronutrients, such as folate, compared with Caucasian survivors.

Bladder Cancer Risk Higher Following Prostate Radiotherapy

Bladder Cancer Risk Higher Following Prostate Radiotherapy

By

The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.

Gender Differences Found in Bladder Cancer Treatment, Survival

Gender Differences Found in Bladder Cancer Treatment, Survival

By

Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.

Well Water Linked to Bladder Cancer

Well Water Linked to Bladder Cancer

Researchers believe arsenic exposure might contribute to higher-than-normal rates.

Well-Timed Follow-Up Reduces Post-Cystectomy Readmissions

Well-Timed Follow-Up Reduces Post-Cystectomy Readmissions

The timing of office visits and telephone calls helped identify a patient at risk for readmission post-radical cystectomy.

Sign Up for Free e-newsletters